Preoperative sentinel lymph node mapping of the prostate using PET/CT fusion imaging and Ga-68-labeled tilmanocept in an animal model

Clinical and Experimental Metastasis

Volumn 29, Issue 7, 2012, Pages 673-680

  Stroup, Sean P ^a   Kane, Christopher J ^a   Farchshchi Heydari, Salman ^b   James, Claude M ^b   Davis, Christopher H ^b   Wallace, Anne M ^c   Hoh, Carl K ^b   Vera, David R ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Pelvic lymph node dissection; PET CT fusion imaging; Prostate cancer; Sentinel lymph node

Indexed keywords

GALLIUM 68; RADIOPHARMACEUTICAL AGENT; TILMANOCEPT GALLIUM GA 68; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; EXPERIMENTAL MODEL; LYMPH NODE DISSECTION; LYMPHATIC SYSTEM EXAMINATION; MALE; NONHUMAN; PELVIS LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PROSTATE; PROSTATE CANCER; PROSTATECTOMY; RADIOACTIVITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE MAPPING;

ANIMALS; DEXTRANS; DOGS; GALLIUM RADIOISOTOPES; LYMPH NODES; LYMPHATIC METASTASIS; MALE; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSTATE; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M PENTETATE;

EID: 84868207516     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-012-9498-9     Document Type: Conference Paper

References (30)

1. Mattei A, Fuechsel FG, Bhatta Dhar N, Warncke SH, Thalmann GN, Krause T, Studer UE (2008) The template of the primary lymphatic landing sites of the prostate should be revisited: Results of a multimodality mapping study. Eur Urol 53:118-125
2. Flocks RH, Culp D, Porto R (1959) Lymphatic spread from prostatic cancer. J Urol 81:194-196
3. Daneshmand S, Quek ML, Stein JP, Lieskovsky G, Cai J, Pinski J, Skinner EC, Skinner DG (2004) Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: Long-term results. J Urol 172:2252-2255
4. Cheng L, Zincke H, Blute ML, Bergstralh EJ, Scherer B, Bostwick DG (2001) Risk of prostate carcinoma death in patients with lymph node metastasis. Cancer 91:66-73
5. Joslyn SA, Konety BR (2006) Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 68:121-125
6. Bader P, Burkhard FC, Markwalder R, Studer UE (2002) Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol 168:514-518
7. Briganti A, Chun FK, Salonia A, Suardi N, Gallina A, Da Pozzo LF, Roscigno M, Zanni G, Valiquette L, Rigatti P, Montorsi F, Karakiewicz PI (2006) Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 50:1006-1013
8. Wawroschek F, Vogt H, Weckermann D, Wagner T, Harzmann R (1999) The sentinel lymph node concept in prostate cancer-first results of gamma probe-guided sentinel lymph node identification. Eur Urol 36:595-600
9. Wawroschek F, Vogt H, Weckermann D, Wagner T, Hamm M, Harzmann R (2001) Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol 166:1715-1719
10. Holl G, Dorn R, Wengenmair H, Weckermann D, Sciuk J (2009) Validation of sentinel lymph node dissection in prostate cancer: Experience in more than 2,000 patients. Eur J Nucl Med Mol Imaging 36:1377-1382
11. Janetschek G, Jeschke S, Leeb K, Prammer P, Ziegerhofer J, Sega W (2007) Sentinel lymph node dissection for localized prostate cancer. Actas Urol Esp 31:686-692
12. Meinhardt W, Valdes Olmos RA, van der Poel HG, Bex A, Horenblas S (2008) Laparoscopic sentinel node dissection for prostate carcinoma: Technical and anatomical observations. BJU Int 102:714-717
13. Winter A, Wawroschek F (2008) Lymphadenectomy in prostate cancer. Radio-guided lymph node mapping: An adequate staging method. Front Radiat Ther Oncol 41:58-67
14. Jeschke S, Beri A, Grull M, Ziegerhofer J, Prammer P, Leeb K, Sega W, Janetschek G (2008) Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer. Eur Urol 53:126-133
15. Weckermann D, Dorn R, Holl G, Wagner T, Harzmann R (2007) Limitations of radioguided surgery in high-risk prostate cancer. Eur Urol 51:1549-1556; discussion 1556-1548
16. Takashima H, Egawa M, Imao T, Fukuda M, Yokoyama K, Namiki M (2004) Validity of sentinel lymph node concept for patients with prostate cancer. J Urol 171:2268-2271
17. Wawroschek F, Wengenmair H, Senekowitsch-Schmidtke R, Hamm M, Henke J, Schonberger T, Hauser A, Erhardt W, Harzmann R (2003) Prostate lymphoscintigraphy for sentinel lymph node identification in canines: Reproducibility, uptake, and biokinetics depending on different injection startegies. Urol Res 31:152-158
18. Vera DR, Wallace AM, Hoh CK, Mattrey RF (2001) A synthetic macromolecule for sentinel node detection: [99mTc]DTPA-mannosyl-dextran. J Nucl Med 42:951-959
19. Hoh CK, Wallace AM, Vera DR (2003) Preclinical studies of [99mTc]DPTA-mannosyl-dextran. Nucl Med Biol 30:457-464
20. Albertini J, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen DS (1996) Lymphatic mapping and sentinel node biopsy and lymphatic mapping of patients with breast cancer. JAMA 276:1818-1822
21. Wallace AM, Hoh CK, Vera DR, Darrah D, Schulteis G (2003) Lymphoseek: A molecular radiopharmceutical for sentinel node detection. Ann Surg Oncol 10:531-538
22. Wallace AM, Hoh CK, Ellner SJ, Darrah DD, Schulteis G, Vera DR (2007) Lymphoseek: A molecular imaging agent for melanoma sentinel lymph node mapping. Ann Surg Oncol 14:913-921
23. Wallace AM, Hoh CK, Limmer KK, Darrah DD, Schulteis G, Vera DR (2009) Sentinel lymph node accumulation of Lymphoseek and Tc-99m-sulfur colloid using a "2-day" protocol. Nucl Med Biol 36:687-692
24. Silberstein JL, Derweesh IH, Kane CJ (2009) Lymph node dissection during robot-assisted radical prostatectomy: Where do we stand? Prostate Cancer Prostatic Dis 12:227-232
25. Warncke SH, Mattei A, Fuechsel FG, Z'Brun S, Krause T, Studer UE (2007) Detection rate and operating time required for cprobe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging. Eur Urol 52:126-133
26. van der Poel HG, Buckle T, Brouwer OR, Olmos RAV, van Leeuwen FWB (2011) Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: Clinical proof of concept of an integrated functional imaging approach using a multimodel tracer. Eur Urol 60:826-833
27. Salem CE, Wallace AM, Hoh CK, Vera DR (2006) A preclinical study of prostate sentinel node mapping with Lymphoseek. J Urol 175:744-748
28. Rossi EC, Ivanova A, Boggess JF (2011) Robotically assisted fluorescence-guided lymph node mapping with ICG for gynecologic malignancies: A feasibility study. Gynecol Oncol 124:78-82
29. Ting R, Aguilera TA, Crisp JL, Hall DJ, Eckelman WC, Vera DR, Tsien RY (2010) Fast 18F labeling of a near-infrared fluorophore enables positron emission tomography and optical imaging of sentinel lymph nodes. Bioconjug Chem 21:1811-1817
30. Emerson DA, Limmer KK, Hall DJ, Han S-Y, Eckelman WC, Kane CJ, Wallace AM, Vera DR (in press) A receptor-targeted fluorescent radiopharmaceutical for multi-reporter sentinel lymph node imaging. Radiology.